Evidence map›Paper›PMID 38571478›Full record

ArticleCanadian journal of psychiatry. Revue canadienne de psychiatrie2024

Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale.

Stephanie Coronado-Montoya, Amal Abdel-Baki, David Crockford, José Côté, Simon Dubreucq, Alina Dyachenko, Benedikt Fischer, Tania Lecomte, Sophie L'Heureux, Clairélaine Ouellet-Plamondon and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Stephanie Coronado-MontoyaDepartment of Psychiatry and Addiction, Université de Montréal, Montréal, Canada.
Amal Abdel-BakiDepartment of Psychiatry and Addiction, Université de Montréal, Montréal, Canada.ORCID 0000-0003-3333-9652
David CrockfordDepartment of Psychiatry, University of Calgary, Calgary, Canada.
José CôtéResearch Centre, Centre Hospitalier de l'Université de Montréal, Montréal, Canada.ORCID 0000-0002-0617-2861
Simon DubreucqDepartment of Psychiatry and Addiction, Université de Montréal, Montréal, Canada.
Alina DyachenkoResearch Centre, Centre Hospitalier de l'Université de Montréal, Montréal, Canada.
Benedikt FischerCentre for Applied Research in Addiction and Mental Health, Simon Fraser University, Vancouver, Canada.ORCID 0000-0002-2186-4030
Tania LecomteDepartment of Psychology, University of Montréal, Montréal, Canada.ORCID 0000-0002-0340-3759
Sophie L'HeureuxClinique Notre-Dame des Victoires, Institut Universitaire en Santé Mentale, Centre Intégré Universitaire de Soins et Services Sociaux de la Capitale Nationale, Québec, Canada.
Clairélaine Ouellet-PlamondonDepartment of Psychiatry and Addiction, Université de Montréal, Montréal, Canada.
Marc-André RoyDepartment of Psychiatry and Neurosciences, Laval University, Québec, Canada.ORCID 0000-0002-0123-6651
Philip TibboDepartment of Psychiatry, Dalhousie University, Halifax, Canada.
Marie VilleneuveDepartment of Psychiatry and Addiction, Université de Montréal, Montréal, Canada.
Didier Jutras-AswadDepartment of Psychiatry and Addiction, Université de Montréal, Montréal, Canada.ORCID 0000-0002-8474-508X
Centre Hospitalier de l’Université de Montréal · CAInstitut Universitaire en Santé Mentale de Québec · CACentres Intégré Universitaires de Santé et de Services Sociaux · CADalhousie University · CAUniversité de Montréal · CAUniversity of Auckland · NZUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCannabis use is common in people with early-phase psychosis (EP) and is associated with worse treatment outcomes. Few targeted interventions for cannabis use behaviour in this population exist, most focusing on abstinence, none focusing on harm reduction. Many people with EP will not seek treatment for their cannabis use with current therapeutic options. Understanding preferences for cannabis-focused harm reduction interventions may be key to improving outcomes. This study aimed to determine preferences of young adults with EP who use cannabis for cannabis-focused harm reduction interventions.

methodsEighty-nine young adults across Canada with EP interested in reducing cannabis-related harms were recruited. An online questionnaire combining conventional survey methodology and two unique discrete choice experiments (DCEs) was administered. One DCE focused on attributes of core harm reduction interventions (DCE 1) and the second on attributes of boosters (DCE 2). We analysed these using mixed ranked-ordered logistic regression models. Preference questions using conventional survey methodology were analysed using summary statistics.

resultsPreferred characteristics for cannabis-focused harm reduction interventions (DCE 1) were: shorter sessions (60 min vs. 10 min, odds ratio (OR): 0.72;

conclusionsFurther research is required to see if technology-based harm reduction interventions for cannabis featuring these preferences translate into greater engagement and improved outcomes in EP patients.

Indexed as

Harm ReductionPatient PreferencePsychotic DisordersAdolescentAdultCanadaCross-Sectional StudiesFemaleHumansMaleMarijuana UseYoung Adultcannabisdiscrete choice experimentexpérience de choix discretsharm reductioninterventions psychosocialespreferencespréférencespsychosepsychosispsychosocial interventionsréduction des méfaits

Identifiers

PMID38571478
PMCPMC11168346
OpenAlexW4393942968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.